FIM
ANIP icon

Foresters Investment Management’s ANI Pharmaceuticals ANIP Stock Holding History

Foresters Investment Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-93,000
Closed -$4.88M – 607
2017
Q3 		$4.88M Buy
93,000
+1,000
+1% +$47.7K 0.08% 247
2017
Q2 		$4.31M Buy
92,000
+4,000
+5% +$193K 0.07% 258
2017
Q1 		$4.36M Buy
88,000
+500
+0.6% +$28.1K 0.08% 248
2016
Q4 		$5.54M Hold
87,500
– – 0.1% 222
2016
Q3 		$5.81M Buy
87,500
+500
+0.6% +$31.3K 0.11% 208
2016
Q2 		$4.86M Buy
87,000
+7,000
+9% +$340K 0.09% 219
2016
Q1 		$2.69M Buy
80,000
+45,500
+132% +$1.54M 0.05% 262
2015
Q4 		$1.56M Sell
34,500
-41,000
-54% -$1.76M 0.03% 275
2015
Q3 		$2.98M Sell
75,500
-23,750
-24% -$1.35M 0.06% 254
2015
Q2 		$6.16M Sell
99,250
-1,250
-1% -$74.4K 0.12% 197
2015
Q1 		$6.29M Sell
100,500
-85,525
-46% -$5.2M 0.12% 184
2014
Q4 		$10.5M Buy
186,025
+9,800
+6% +$432K 0.21% 155
2014
Q3 		$4.98M Buy
176,225
+21,700
+14% +$650K 0.11% 200
2014
Q2 		$5.32M Buy
154,525
+10,700
+7% +$336K 0.11% 200
2014
Q1 		$4.51M Buy
+143,825
New +$3.82M 0.1% 208

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Foresters Investment Management's ANIP Position: Q4 2017 in Review

Foresters Investment Management sold out of ANI Pharmaceuticals (ANIP) in Q4 2017, closing a stake of 93,000 shares — an estimated $4.88M sold.

Foresters Investment Management first reported a position in ANIP in Q1 2014 and held it in 15 quarters. The position peaked at $10.5M in Q4 2014. 163 funds tracked by Wall St. Rank hold ANIP as of Q4 2017.

  • Foresters Investment Management reported no remaining ANI Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Foresters Investment Management sold 93,000 ANI Pharmaceuticals shares in Q4 2017, an estimated $4.88M.
  • Foresters Investment Management first reported a position in ANI Pharmaceuticals in Q1 2014 and held it in 15 quarters.
  • Foresters Investment Management's ANI Pharmaceuticals position peaked at $10.5M in Q4 2014.
  • 163 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q4 2017.

Based on Foresters Investment Management's 13F filing for Q4 2017, filed 14 Feb 2018.